ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

SERA vs BNR // PIOTROSKI F-SCORE QUALITY

Sera Prognostics Inc. (Class A) (NASDAQ) VS. Burning Rock Biotech Limited (NASDAQ) • 15-METRIC TALLY: SERA 1 — BNR 6
▲ PIOTROSKI F-SCORE QUALITY LEADER: BNR
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (SERA VS. BNR) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC SERA BNR SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin -30.00% 74.70% -104.70 BNR /gross-margins <GO>
Return on Invested Capital (ROIC) -35.00% -35.00% 0.00 TIE /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield — -4.14% — TIE /fcf-yield <GO>
Operating Margin -60.00% -10.20% -49.80 BNR /operating-margins <GO>
Net Profit Margin -60.00% -10.30% -49.70 BNR /net-margins <GO>
Revenue Growth (YoY) 5.20% 9.20% -4.00 BNR /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity 0.20 0.20 0.00 TIE /balance-sheet <GO>
Piotroski F-Score Quality ACTIVE 4/9 5/9 -1.00 BNR /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 52.1 39.1 +13.00 SERA /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $81.3M $116.5M -$35.3M BNR /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR SERA REV BNR REV SERA GROSS % BNR GROSS % SERA FCF BNR FCF
FY 2025 $81.0K $77.2M -50.0% 74.7% -$26.3M -$4.8M
FY 2024 $77.0K $70.7M -6.5% 70.3% -$14.2M -$13.4M
FY 2023 $306.0K $75.7M — — -$27.2M -$36.0M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
SERA // BETA —
BNR // BETA —